Blood compatibility evaluations of CaCO 3 particles
Authors:
- 13 August 2021
- journal article
- research article
- Published by IOP Publishing in Biomedical Materials
- Vol. 16 (5) , 055010
Abstract
CaCO 3 particles, due to their unique properties such as biodegradation, pH-sensitivity, and porous surface, have been widely used as carrier materials for delivering drugs, genes, vaccines, and other bioactive molecules. In these applications, CaCO 3 particles are often administered intravenously. In this sense, the interaction between CaCO 3 particles and blood components plays a key role in their delivery efficacy and biosafety, though the hemocompatibility of CaCO 3 particles has not been evaluated until now. Deficiency in the biosafety information has delayed the clinical use of CaCO 3 particles in delivery systems. In this work, we investigated the biosafety of CaCO 3 particles, focusing on their in vitro and in vivo effects on key blood components (red blood cells, platelets, etc) and coagulation functions. We found in vitro that high concentrations of CaCO 3 particles can cause the aggregation and hemolysis of red blood cells, with platelet activation and coagulation prolongation. In vivo , we found that intravenously injected CaCO 3 particles at 50 mg kg −1 significantly disturbed the red blood cells, and platelet-related blood routine indexes, but did not induce visible abnormalities in the tissue structures of the key organs. Overall, these effects may be due to the enormous adsorption capability of the porous surface of CaCO 3 particles. 0.1 mg ml −1 of the CaCO 3 particles exhibit excellent compatibility for their practical applications. These results would be expected to greatly promote the in vivo applications and clinical use of CaCO 3 particles in biomedicine.Keywords
Funding Information
- Natural Science Foundation of Hunan Province (2018JJ3381)
- National Natural Science Foundation of China (81904060)
This publication has 27 references indexed in Scilit:
- Effects of thermosensitive poly(N-isopropylacrylamide) on blood coagulationJournal of Materials Chemistry B, 2016
- Peptide nanofiber–CaCO3 composite microparticles as adjuvant-free oral vaccine delivery vehiclesJournal of Materials Chemistry B, 2015
- Blood Compatibility Evaluations of Fluorescent Carbon DotsACS Applied Materials & Interfaces, 2015
- Designed preparation of polyacrylic acid/calcium carbonate nanoparticles with high doxorubicin payload for liver cancer chemotherapyCrystEngComm, 2015
- pH-Controlled Gas-Generating Mineralized Nanoparticles: A Theranostic Agent for Ultrasound Imaging and Therapy of CancersACS Nano, 2015
- Effects of the gene carrier polyethyleneimines on structure and function of blood componentsBiomaterials, 2013
- Platelet expression of CD62P in hypotrophic newbornsPlatelets, 2011
- Platelet function alterations and their relation to P-selectin (CD62P) expression in children with iron deficiency anemiaBlood Coagulation & Fibrinolysis, 2011
- Synthetic nanoparticle vaccines produced by layer-by-layer assembly of artificial biofilms induce potent protective T-cell and antibody responses in vivoVaccine, 2011
- Flow Cytometric Parameters for Characterizing Platelet Activation by Measuring P-Selectin (CD62) Expression: Theoretical Consideration and Evaluation in Thrombin-Treated Platelet PopulationsBiochemical and Biophysical Research Communications, 2000